EBIT: Income before interest and taxes.
Quest Diagnostics Incorporated (DGX) had EBIT of $300.00M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$2.37B |
|
$194.00M |
|
$1.59B |
|
$771.00M |
|
$2.07B |
|
$300.00M |
|
$-34.00M |
|
$266.00M |
|
$266.00M |
|
$200.00M |
|
$208.00M |
|
$208.00M |
|
$200.00M |
|
|
EBIT |
$300.00M |
-- |
|
111.00M |
|
112.00M |
|
$1.74 |
|
$1.72 |
|
| Balance Sheet Financials | |
$2.23B |
|
$1.81B |
|
$11.73B |
|
$13.95B |
|
$2.30B |
|
$3.80B |
|
$5.19B |
|
$7.49B |
|
$6.47B |
|
$-2.55B |
|
$6.47B |
|
111.00M |
|
| Cash Flow Statement Financials | |
$154.00M |
|
$-213.00M |
|
$-153.00M |
|
$686.00M |
|
$474.00M |
|
$-212.00M |
|
$22.00M |
|
$-90.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|